Your browser doesn't support javascript.
loading
Successful Long-Term Anticoagulation with Low Molecular Weight Heparin in a Patient with Mechanical Mitral Valve and Atrial Flutter.
Aljaziri, Narjis; Alkhaleel, Meshail S; Alrajhi, Norah; Alghamdi, Mohammed; Aljizeeri, Ahmed.
Afiliação
  • Aljaziri N; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alkhaleel MS; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Alrajhi N; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alghamdi M; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • Aljizeeri A; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
J Saudi Heart Assoc ; 34(3): 163-165, 2022.
Article em En | MEDLINE | ID: mdl-36447605
ABSTRACT
Mechanical heart valves are associated with high risk of thrombosis and thromboembolic complications. Vitamin K antagonist is the only approved oral medication for the anticoagulation in cases of mechanical heart valves. This poses a challenge in cases where vitamin K antagonists are contraindicated. Although temporary anticoagulation with low molecular weight heparin is common among pregnant patients with mechanical heart valves, data about long term anticoagulation with low molecular weight heparin is limited. We report a successful long-term anticoagulation with low molecular weight heparin in a patient with mechanical mitral valve and atrial flutter.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article